ClinicalTrials.gg
RecruitingNCT06330181Updated Oct 5, 2026

Virtual Walking Therapy for Neuropathic Pain Following Incomplete Spinal Cord Injury

An interventional study of VR Game 1 and VR Game 2 in Spinal Cord Injuries and Neuropathic Pain, sponsored by Texas A&M University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Texas A&M University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.
Updated Oct 5, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 968 studies in Spinal Cord Injuries with a site in United States — 249 open to participants now, 308 under way, 7 of them phase 3. Spinal Cord Injuries · United States.

Planned enrollment
215th of 836
48 · median 24
Started
2024
with 51 others
No phase
601 of 968
189 open now
Primary completion
2027-04
later than 136 of 307 live
Registered
813th of 968
by date

Among the 968 studies in Spinal Cord Injuries with a site in United States, this one is the 215th largest by planned enrollment of the 836 interventional ones that give a count, is one of 52 that started in 2024, is one of 601 with no phase, reaches primary completion later than 136 of the 307 other live ones, and was the 813th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

249 of the 968 studies in Spinal Cord Injuries with a site in United States are open now. Recruiting first, the newest first:

244 more — sign in →

All 249 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 968 studies in Spinal Cord Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with incomplete spinal cord injury.

Read the detailed description

Many people with SCI experience neuropathic pain. Neuropathic pain is often described as sharp, burning, or electric. 'Traditional' treatments often do not do a good job of reducing neuropathic pain. Therefore, it is important to see if 'non-traditional' treatments might work. Scientists think that neuropathic pain occurs in SCI because the sensations coming from the eyes and up the spinal cord to the brain do not match what the brain thinks it told the body to do. This 'mismatch' may result in changes in the brain that make neuropathic pain possible. Virtual reality walking may potentially reduce this 'mismatch' by creating the 'illusion' that the person is walking. The brain then thinks it is telling the body to walk AND the information coming from the eyes matches its instructions. This 'matching' may reverse the brain changes that make neuropathic pain possible. The current study is specifically focused on individuals whose SCI has been classified as incomplete (ASIA B, C, or D).

03

Conditions studied

  • Spinal Cord Injuries
  • Neuropathic Pain

Keywords

  • Spinal Cord Diseases
  • Central Nervous System Diseases
  • Trauma, Nervous System
  • Peripheral Nervous System Diseases
  • Neuromuscular Diseases
  • Pain
  • Neurologic Manifestations
  • Spinal Cord Injuries
  • Neuralgia
  • Wounds and Injuries
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

The study will recruit individuals with incomplete injury (American Spinal Injury Association [ASIA] classification B, C, or D) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criteria will include:

  1. Must have persistent NP symptoms that are of daily severity of at least 4/10 for 3 or more months
  2. Must endorse more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI
  3. Must be 18 years of age or older
  4. Must be more than one and a half years post-injury to begin study (can be screened at an earlier time for eligibility)
  5. Must have mobile connectivity with usable service
  6. Must be stable on pain medication for 1 or more months
  7. Must be cleared on the VRWalk physical activity clearance scale
  8. Must not have motion sickness that interferes with daily life
  9. Must use a wheelchair at least 75% of the time

Exclusion criteria

Exclusion Criteria:

  1. Individuals with Injury levels between C1 and C4
  2. Individuals under the age of 18
  3. Individuals who were injured within the past year
  4. Individuals who cannot comprehend spoken English
  5. Individuals who are in prison
  6. Individuals who are blind
  7. Individuals who experience severe motion sickness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
48 participants (estimated)

Study arms

  • Active comparator
    Virtual reality (VR) game 1

    Participants will be asked to play a virtual reality game twice a day for 10 days.

    Other: VR Game 1

  • Active comparator
    Virtual reality (VR) game 2

    Participants will be asked to play a virtual reality game twice a day for 10 days.

    Other: VR Game 2

Interventions

  • OtherVR Game 1

    Individuals playing VR game 1 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart

  • OtherVR Game 2

    Individuals playing VR game 2 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity

    The Numeric Rating Scale (NRS) measures pain intensity via a 0-10 numeric rating scale 0-10 where 0 is no pain, and 10 is the worst pain imaginable.

    Time frame: Baseline - final follow up (up to 18 months)

Secondary outcomes

  1. Change in Pain Quality

    The Neuropathic Pain Scale (NPS) assesses the distinct pain qualities, including sharpness, heat/cold, dullness, intensity, overall unpleasantness, and surface vs. deep pain. The NPS consists of 10 items. 0 equals 'No sensation' and 10 equals 'Worst sensation imaginable.' All the items are rated 0-10 scale, with a higher score indicative of more neuropathic pain for each type of respective pain.

    Time frame: Baseline - final follow up (up to 18 months)

  2. Change in Pain Interference

    The International Spinal Cord Injury Pain Basic Data Set version 2.0 interference assesses the degree to which pain interferes with day-to-day activities, mood, and sleep. Items are scored on a 0-10 numeric rating scale, and scores are summed to yield an interference score ranging from 0 to 30. Higher scores indicate greater interference from pain.

    Time frame: Baseline - final follow up (up to 18 months)

  3. Post treatment change

    The Patient Global Impression of Change is a one item 7 point Likert item assessing improvement of the participants' overall status. A score of 1 is 'Very Much Improved', and a score of 7 is 'Very Much Worse.' Higher scores indicate less perceived improvement. Range of scores: 1-7

    Time frame: at follow up (up to 18 months)

  4. Change in mood

    Mood will be assessed using the Patient Health Questionnaire-9. Participants will be asked to rate how often they have been bothered by specific problems on a 4-point Likert scale, where 0 is 'Not at all,' and 3 is 'Nearly every day.' The items are summed to yield a score ranging from 0-27. Higher scores indicate worse mood.

    Time frame: Baseline - final follow up (up to 18 months)

  5. Change in quality of life

    Quality of life is assessed by the Satisfaction with Life Scale. This is a 5 item survey. Response options are a 7-point Likert scale where 1 is 'Strongly disagree,' and 7 is 'Strongly agree'. Items may be assessed individually or by summing items. Range of scores: 5-35. Higher scores indicate more satisfaction in life

    Time frame: Baseline - final follow up (up to 18 months)

  6. Neurological changes

    For eligible and interested participants, functional Magnetic Resonance Imaging (fMRI) will be used to observe neurological changes. Pre and post-study images will be compared by experienced researchers.

    Time frame: Baseline - 6 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Apr 2027, 28 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 28 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 5, 2026: primary completion Jan 2026 → Apr 2027 and completion Jan 2027 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2024
First posted
Mar 26, 2024
StartActual
Dec 2, 2024
Primary completionEst.
Apr 2027was Jan 2026
CompletionEst.
Oct 2027was Jan 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 2026→Apr 2027
Oct 5, 2026
Study completion
Jan 2027→Oct 2027
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Primary completion Jan 2026→Apr 2027
    Study completion Jan 2027→Oct 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06330181
Collaborators
United States Department of Defense, Immersive Experience Labs
Responsible party
Sponsor
First posted
Mar 26, 2024
Start date
Dec 2, 2024
Primary completion
Apr 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Ami Lisenbee
Contact
sci@vrwalk.org
804-569-5965

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion